Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atypical depression.

E K Silberman, J L Sullivan

    The Psychiatric Clinics of North America
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Atypical depression, marked by anxiety or reversed symptoms like oversleeping and overeating, can be challenging to diagnose. This review discusses biologic treatments, including monoamine oxidase inhibitors and heterocyclic antidepressants, for managing these complex cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy.

    Leukemia·2015
    Same author

    On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans.

    Acta physiologica (Oxford, England)·2014
    Same author

    Learning priorities of staff, residents, and students for a third-year psychiatric clerkship.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    Robotic training and kinematic analysis of arm and hand after incomplete spinal cord injury: a case study.

    IEEE ... International Conference on Rehabilitation Robotics : [proceedings]·2012
    Same author

    Putative hepatoprotective effects of coffee.

    Alimentary pharmacology & therapeutics·2007
    Same author

    Is homocysteine an iron-dependent cardiovascular risk factor?

    Kidney international·2006
    Same journal

    Digital Mental Health: Progress but not Perfection.

    The Psychiatric clinics of North America·2026
    Same journal

    Advances in Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    The Future of Digital Mental Health: A Literature Review.

    The Psychiatric clinics of North America·2026
    Same journal

    Assessment and Treatment of Posttraumatic Stress Disorder via Digital Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    Treatment of Obsessive-Compulsive Disorder via Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    Digital Mental Health Treatments for Depression.

    The Psychiatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Psychiatry and Behavioral Sciences
    • Neuroscience
    • Pharmacology

    Background:

    • Atypical depression presents with distinct features like phobic anxiety or reversed vegetative symptoms (hypersomnia, hyperphagia).
    • Patients may seek treatment directly or be misdiagnosed within other categories like personality disorders or somatic complaints.
    • Understanding atypical depression is crucial for effective therapeutic intervention.

    Purpose of the Study:

    • To review and discuss the comparative efficacy of various biologic treatments for atypical depressions.
    • To highlight the diagnostic challenges associated with atypical depression presentations.
    • To provide insights into treatment strategies for patients with atypical depressive symptoms.

    Main Methods:

    • Literature review of studies on atypical depression and its treatment.

    Related Experiment Videos

  • Analysis of the roles of monoamine oxidase inhibitors (MAOIs).
  • Evaluation of heterocyclic antidepressants (TCAs) and other biologic interventions.

    • Main Results:

    • Monoamine oxidase inhibitors (MAOIs) are often effective for atypical depression, particularly when vegetative symptoms are prominent.
    • Heterocyclic antidepressants (TCAs) and newer agents may also be considered, though response patterns can vary.
    • The discussion encompasses the broader landscape of biological treatments for this subtype.

    Conclusions:

    • Biologic treatments, including MAOIs and TCAs, play a significant role in managing atypical depression.
    • Accurate diagnosis is essential to optimize treatment selection for patients with atypical depressive features.
    • Further research may refine treatment algorithms for specific presentations of atypical depression.